Trial intelligence / Profile preview

DEFINITION: High vs Standard Dose Heparin for Radial Artery Occlusion

NCT04561648Recruiting

Sponsor
Instituto Nacional de Cardiología Ignacio Chávez
Start
Aug 2020
Primary completion
Dec 2025
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of heparin in Radial artery occlusion (RAO) (2 arms), sponsored by Instituto Nacional de Cardiología Ignacio Chávez. Primary endpoint: Radial Artery Occlusion at 24 hours. Started Aug 2020; status: recruiting.

02

Drugs

heparin
03

Conditions

Radial artery occlusion (RAO)

Beyond the preview

Go deeper on NCT04561648.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04561648.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call